Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer

NCT00721916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: SOL(The combination therapy of S-1, Leucovorin, and Oxaliplatin)
DRUG: mFOLFOX6(The combination therapy of 5-FU, l-LV and Oxaliplatin)

Sponsor

Taiho Pharmaceutical Co., Ltd.

Collaborators

[object Object]